LEMAITRE VASCULAR INC (LMAT) Stock Fundamental Analysis
USA - NASDAQ:LMAT - US5255582018 - Common Stock
84.6051 USD
-3.19 (-3.64%)
LMAT gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 190 industry peers in the Health Care Equipment & Supplies industry. LMAT gets an excellent profitability rating and is at the same time showing great financial health properties. LMAT has a correct valuation and a medium growth rate. These ratings would make LMAT suitable for quality investing!
1. Profitability
1.1 Basic Checks
In the past year LMAT was profitable.
In the past year LMAT had a positive cash flow from operations.
In the past 5 years LMAT has always been profitable.
In the past 5 years LMAT always reported a positive cash flow from operatings.
1.2 Ratios
With an excellent Return On Assets value of 8.16%, LMAT belongs to the best of the industry, outperforming 91.58% of the companies in the same industry.
The Return On Equity of LMAT (12.99%) is better than 89.47% of its industry peers.
LMAT's Return On Invested Capital of 7.70% is amongst the best of the industry. LMAT outperforms 84.74% of its industry peers.
LMAT had an Average Return On Invested Capital over the past 3 years of 8.26%. This is in line with the industry average of 8.43%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.16% | ||
| ROE | 12.99% | ||
| ROIC | 7.7% |
ROA(3y)7.77%
ROA(5y)8.17%
ROE(3y)10.28%
ROE(5y)10.74%
ROIC(3y)8.26%
ROIC(5y)8.93%
1.3 Margins
LMAT has a better Profit Margin (20.08%) than 93.68% of its industry peers.
LMAT's Profit Margin has improved in the last couple of years.
LMAT has a Operating Margin of 23.34%. This is amongst the best in the industry. LMAT outperforms 93.68% of its industry peers.
In the last couple of years the Operating Margin of LMAT has grown nicely.
Looking at the Gross Margin, with a value of 69.11%, LMAT is in the better half of the industry, outperforming 77.37% of the companies in the same industry.
In the last couple of years the Gross Margin of LMAT has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 23.34% | ||
| PM (TTM) | 20.08% | ||
| GM | 69.11% |
OM growth 3Y0.27%
OM growth 5Y5.61%
PM growth 3Y4.76%
PM growth 5Y5.57%
GM growth 3Y1.48%
GM growth 5Y0.13%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), LMAT is destroying value.
The number of shares outstanding for LMAT has been increased compared to 1 year ago.
Compared to 5 years ago, LMAT has more shares outstanding
The debt/assets ratio for LMAT is higher compared to a year ago.
2.2 Solvency
An Altman-Z score of 7.49 indicates that LMAT is not in any danger for bankruptcy at the moment.
LMAT has a better Altman-Z score (7.49) than 87.89% of its industry peers.
LMAT has a debt to FCF ratio of 3.21. This is a good value and a sign of high solvency as LMAT would need 3.21 years to pay back of all of its debts.
LMAT's Debt to FCF ratio of 3.21 is amongst the best of the industry. LMAT outperforms 86.84% of its industry peers.
LMAT has a Debt/Equity ratio of 0.46. This is a healthy value indicating a solid balance between debt and equity.
LMAT's Debt to Equity ratio of 0.46 is in line compared to the rest of the industry. LMAT outperforms 42.63% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.46 | ||
| Debt/FCF | 3.21 | ||
| Altman-Z | 7.49 |
ROIC/WACC0.9
WACC8.56%
2.3 Liquidity
LMAT has a Current Ratio of 13.96. This indicates that LMAT is financially healthy and has no problem in meeting its short term obligations.
LMAT has a Current ratio of 13.96. This is amongst the best in the industry. LMAT outperforms 98.42% of its industry peers.
LMAT has a Quick Ratio of 11.74. This indicates that LMAT is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of LMAT (11.74) is better than 95.79% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 13.96 | ||
| Quick Ratio | 11.74 |
3. Growth
3.1 Past
LMAT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 23.35%, which is quite impressive.
The Earnings Per Share has been growing by 17.13% on average over the past years. This is quite good.
Looking at the last year, LMAT shows a quite strong growth in Revenue. The Revenue has grown by 14.11% in the last year.
LMAT shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.41% yearly.
EPS 1Y (TTM)23.35%
EPS 3Y15.47%
EPS 5Y17.13%
EPS Q2Q%15.38%
Revenue 1Y (TTM)14.11%
Revenue growth 3Y12.5%
Revenue growth 5Y13.41%
Sales Q2Q%15.01%
3.2 Future
LMAT is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.76% yearly.
LMAT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.67% yearly.
EPS Next Y20.02%
EPS Next 2Y14.31%
EPS Next 3Y13.26%
EPS Next 5Y9.76%
Revenue Next Year13.91%
Revenue Next 2Y11.23%
Revenue Next 3Y11.24%
Revenue Next 5Y9.67%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
LMAT is valuated quite expensively with a Price/Earnings ratio of 41.07.
Compared to the rest of the industry, the Price/Earnings ratio of LMAT indicates a somewhat cheap valuation: LMAT is cheaper than 68.95% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.29, LMAT is valued quite expensively.
The Price/Forward Earnings ratio is 33.38, which means the current valuation is very expensive for LMAT.
LMAT's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. LMAT is cheaper than 71.58% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of LMAT to the average of the S&P500 Index (22.80), we can say LMAT is valued slightly more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 41.07 | ||
| Fwd PE | 33.38 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of LMAT indicates a somewhat cheap valuation: LMAT is cheaper than 73.16% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, LMAT is valued a bit cheaper than the industry average as 77.89% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 36.61 | ||
| EV/EBITDA | 23.8 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates LMAT does not grow enough to justify the current Price/Earnings ratio.
The excellent profitability rating of LMAT may justify a higher PE ratio.
A more expensive valuation may be justified as LMAT's earnings are expected to grow with 13.26% in the coming years.
PEG (NY)2.05
PEG (5Y)2.4
EPS Next 2Y14.31%
EPS Next 3Y13.26%
5. Dividend
5.1 Amount
With a yearly dividend of 0.86%, LMAT is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 1.74, LMAT pays a better dividend. On top of this LMAT pays more dividend than 91.58% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.38, LMAT's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.86% |
5.2 History
The dividend of LMAT is nicely growing with an annual growth rate of 13.60%!
LMAT has been paying a dividend for at least 10 years, so it has a reliable track record.
LMAT has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)13.6%
Div Incr Years13
Div Non Decr Years13
5.3 Sustainability
34.45% of the earnings are spent on dividend by LMAT. This is a low number and sustainable payout ratio.
The dividend of LMAT is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP34.45%
EPS Next 2Y14.31%
EPS Next 3Y13.26%
NASDAQ:LMAT (9/25/2025, 10:46:54 AM)
84.6051
-3.19 (-3.64%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners95.69%
Inst Owner Change-2.07%
Ins Owners8.54%
Ins Owner Change-9.35%
Market Cap1.92B
Analysts78.82
Price Target106.87 (26.32%)
Short Float %6.46%
Short Ratio8.39
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.86% |
Yearly Dividend0.64
Dividend Growth(5Y)13.6%
DP34.45%
Div Incr Years13
Div Non Decr Years13
Ex-Date
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.86%
Min EPS beat(2)-5.52%
Max EPS beat(2)3.81%
EPS beat(4)2
Avg EPS beat(4)1.56%
Min EPS beat(4)-5.52%
Max EPS beat(4)10.44%
EPS beat(8)6
Avg EPS beat(8)4.62%
EPS beat(12)8
Avg EPS beat(12)3.08%
EPS beat(16)8
Avg EPS beat(16)-1.76%
Revenue beat(2)2
Avg Revenue beat(2)1.31%
Min Revenue beat(2)0.79%
Max Revenue beat(2)1.83%
Revenue beat(4)3
Avg Revenue beat(4)0.17%
Min Revenue beat(4)-2.38%
Max Revenue beat(4)1.83%
Revenue beat(8)4
Avg Revenue beat(8)-0.31%
Revenue beat(12)6
Avg Revenue beat(12)-0.07%
Revenue beat(16)7
Avg Revenue beat(16)-0.44%
PT rev (1m)0.27%
PT rev (3m)0.27%
EPS NQ rev (1m)0.65%
EPS NQ rev (3m)5.28%
EPS NY rev (1m)0%
EPS NY rev (3m)6%
Revenue NQ rev (1m)-0.04%
Revenue NQ rev (3m)2.15%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.14%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 41.07 | ||
| Fwd PE | 33.38 | ||
| P/S | 8.16 | ||
| P/FCF | 36.61 | ||
| P/OCF | 32.6 | ||
| P/B | 5.28 | ||
| P/tB | 7.27 | ||
| EV/EBITDA | 23.8 |
EPS(TTM)2.06
EY2.43%
EPS(NY)2.53
Fwd EY3%
FCF(TTM)2.31
FCFY2.73%
OCF(TTM)2.6
OCFY3.07%
SpS10.36
BVpS16.02
TBVpS11.64
PEG (NY)2.05
PEG (5Y)2.4
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.16% | ||
| ROE | 12.99% | ||
| ROCE | 10.02% | ||
| ROIC | 7.7% | ||
| ROICexc | 18.52% | ||
| ROICexgc | 32.83% | ||
| OM | 23.34% | ||
| PM (TTM) | 20.08% | ||
| GM | 69.11% | ||
| FCFM | 22.3% |
ROA(3y)7.77%
ROA(5y)8.17%
ROE(3y)10.28%
ROE(5y)10.74%
ROIC(3y)8.26%
ROIC(5y)8.93%
ROICexc(3y)14.32%
ROICexc(5y)13.54%
ROICexgc(3y)28.83%
ROICexgc(5y)29.82%
ROCE(3y)10.75%
ROCE(5y)11.62%
ROICexcg growth 3Y-0.4%
ROICexcg growth 5Y7.52%
ROICexc growth 3Y9.22%
ROICexc growth 5Y8.43%
OM growth 3Y0.27%
OM growth 5Y5.61%
PM growth 3Y4.76%
PM growth 5Y5.57%
GM growth 3Y1.48%
GM growth 5Y0.13%
F-Score5
Asset Turnover0.41
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.46 | ||
| Debt/FCF | 3.21 | ||
| Debt/EBITDA | 2.59 | ||
| Cap/Depr | 63.73% | ||
| Cap/Sales | 2.74% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 90.57% | ||
| Profit Quality | 111.05% | ||
| Current Ratio | 13.96 | ||
| Quick Ratio | 11.74 | ||
| Altman-Z | 7.49 |
F-Score5
WACC8.56%
ROIC/WACC0.9
Cap/Depr(3y)60.87%
Cap/Depr(5y)52.43%
Cap/Sales(3y)2.97%
Cap/Sales(5y)2.88%
Profit Quality(3y)96.62%
Profit Quality(5y)110.46%
High Growth Momentum
Growth
EPS 1Y (TTM)23.35%
EPS 3Y15.47%
EPS 5Y17.13%
EPS Q2Q%15.38%
EPS Next Y20.02%
EPS Next 2Y14.31%
EPS Next 3Y13.26%
EPS Next 5Y9.76%
Revenue 1Y (TTM)14.11%
Revenue growth 3Y12.5%
Revenue growth 5Y13.41%
Sales Q2Q%15.01%
Revenue Next Year13.91%
Revenue Next 2Y11.23%
Revenue Next 3Y11.24%
Revenue Next 5Y9.67%
EBIT growth 1Y20%
EBIT growth 3Y12.81%
EBIT growth 5Y19.77%
EBIT Next Year37.11%
EBIT Next 3Y21.1%
EBIT Next 5YN/A
FCF growth 1Y176.09%
FCF growth 3Y7.14%
FCF growth 5Y28.96%
OCF growth 1Y129.52%
OCF growth 3Y7.93%
OCF growth 5Y25.49%